The Society of Toxicology (SOT) Nominating Committee is pleased to announce the results of the 2015-2016 election.
2015–2016 Vice President-Elect is Patricia E. Ganey who is a professor of Pharmacology and Toxicology at Michigan State University.
Dr. Ganey is active in training medical and graduate students and in research. She has noted that: “The SOT has a strong tradition of involving trainees and other young scientists in its activities. It is critical to the excellence and long-term health of the Society to continue to attract this group of people to the discipline of toxicology and to the SOT as a professional home....As SOT President, I will work to ensure that the SOT continues to be the premier professional society in Toxicology and to provide services that promote the career development of its members. In addition, I will increase efforts to enhance the reputation of the discipline. The SOT and its membership have much to contribute as leaders in global efforts to improve human and environmental health.” Dr. Ganey joined SOT in 1987.
2015–2016 Secretary-Elect is Ruth A. Roberts who is a senior director at AstraZeneca and an adjunct professor at the University of Birmingham, United Kingdom.
Dr. Roberts has stated that: “My vision is for a Society with a stronger global focus on the science of toxicology and its translational power in transforming discovery science, practice, policy, and other domains of implementation….Harnessing our power by convening the membership in new and innovative forums will allow us to address seemingly intractable and persistent problems that plague society. I will bring a unique perspective on how to address these challenges and embrace these opportunities on a global scale, capitalizing on the emerging world powers in science and research.” She joined SOT in 1998.
2015–2018 Councilor is Rosonald R. Bell who serves as both regulatory strategy lead and a drug safety team lead at Pfizer Inc., Groton, Connecticut.
Dr. Bell expressed his vision for the future: “By continuing its path of excellence and addressing the new challenges of tomorrow through creative programming, education, and service offerings, the Society of Toxicology and its membership will continue to thrive as leads of scientific creativity, rigor, and integrity and contribute significantly to the health care challenges ahead….The discoveries of scientists help to shape our views about ourselves and our place in the universe. I am committed on a personal and professional level to further this approach and to strengthen the Society’s role in leading sciences on a global level.” He joined SOT in 1998.
2015–2018 Councilor is Tao Wang who has been with Novartis Pharmaceuticals for more than a decade and is currently an associate director in the Preclinical Safety Department.
She has stated that her vision for the Society is closely aligned with the SOT Strategic Plan: “I will strive to increase the interactions among toxicologists and scientists from other disciplines to expand the impact of our Society and toxicology in general on public health….; promote the participation of women and minorities in SOT, not only as members, but also as active participants….; expand global interactions and promote SOT as a truly international forum for the discussion of global issues impacting the toxicology field; and continue to actively promote student and postdoc mentoring and leadership development. I strongly believe that these members are the future of our Society.” Dr. Wang joined the Society in 1997.
The Awards Committee members include: Matthew J. Campen, University of New Mexico, SOT member since 2002; Nathan J. Cherrington, University of Arizona, SOT member since 1997; Elaine M. Faustman, University of Washington, SOT member since 1984; and Raymond G. York, RG York & Associates, LLC, SOT member since 1986.
The Membership Committee members include: Silvia B. Barros, University of São Paulo, School of Pharmaceutical Sciences, SOT member since 2001; Peyton L. Myers, US Food and Drug Administration, SOT member since 2000; and Martin L. Stephens, Johns Hopkins Bloomberg School of Public Health, SOT member since 2007.
The Nominating Committee members include: SOT Past President Michael P. Holsapple, Covance Laboratories, Inc.; SOT member since 1985; from the Regional Chapters is Lynette K. Rogers, The Research Institute at Nationwide Children’s Hospital/The Ohio State University, SOT member since 2004; from the Special Interest Groups Sharmilee P. Sawant, Halyard Health, Inc., SOT member since 2001; from the Specialty Sections Angela J. Harris, Environ, SOT member since 2003.
The members of the SOT 2014–2015 Nominating Committee include Chair William Slikker Jr., US Food and Drug Administration-National Center for Toxicological Research; Kim Boekelheide, Brown University; George B. Corcoran, Wayne State University; Brian S. Cummings, University of Georgia; Bruce A. Fowler, Consultant, Adjunct Professor, Emory School of Public Health, and Presidents Professor, University of Alaska-Fairbanks; Hanan N. Ghantous, US Food and Drug Administration-Center for Drug Evaluation and Research; B. Paige Lawrence, University of Rochester Medical Center; Anthony M. Ndifor, Janssen R&D, Jean F. Regal, University of Minnesota Medical School; and Lois D. Lehman-McKeeman, Bristol-Myers Squibb Company (SOT Council Contact).